| Ident. | Authors (with country if any) | Title |
|---|
| 000042 |
Travis S. Tierney [États-Unis] ; Andres M. Lozano [Canada] | Surgical Treatment for Secondary Dystonia |
| 000064 |
Robert Chinnapongse [États-Unis] ; Kristen Gullo [États-Unis] ; Paul Nemeth [États-Unis] ; YUXIN ZHANG [États-Unis] ; Lynn Griggs [États-Unis] | Safety and Efficacy of Botulinum Toxin Type B for Treatment of Sialorrhea in Parkinson's Disease: A Prospective Double-Blind Trial |
| 000374 |
Joana Damasio [Royaume-Uni, Portugal] ; Mark J. Edwards [Royaume-Uni] ; Araceli Alonso-Canovas [Royaume-Uni, Espagne] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Georg K Gi [Royaume-Uni, Suisse] ; Kailash P. Bhatia [Royaume-Uni] | The Clinical Syndrome of Primary Tic Disorder Associated with Dystonia: A Large Clinical Series and a Review of the Literature |
| 000395 |
Alessandra Scontrini [Italie] ; Antonella Conte [Italie] ; Giovanni Fabbrini [Italie] ; Carlo Colosimo [Italie] ; Flavio Di Stasio [Italie] ; Gina Ferrazzano [Italie] ; Alfredo Berardelli [Italie] | Somatosensory Temporal Discrimination Tested in Patients Receiving Botulinum Toxin Injection for Cervical Dystonia |
| 000536 |
Codrin Lungu [États-Unis] ; Barbara I. Karp [États-Unis] ; Katharine Alter [États-Unis] ; Regina Zolbrod [États-Unis] ; Mark Hallett [États-Unis] | Long-Term Follow-up of Botulinum Toxin Therapy for Focal Hand Dystonia: Outcome at 10 Years or More |
| 000571 |
Alessandro Picelli [Italie] ; Nicola Smania [Italie] ; Ilaria Storti [Italie] ; Daniele Munari [Italie] ; Carla Fontana [Italie] ; Antonio Fiaschi [Italie] ; Valter Santilli [Italie] ; Stefano Tamburin [Italie] | Immediate Versus Delayed Electrical Stimulation Boosts Botulinum Toxin Effect: A Pilot Study |
| 000572 |
Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Carla Cordivari [Royaume-Uni] | Immediate Response to Botulinum Toxin Injections in Patients with Fixed Dystonia |
| 000618 |
Joseph Jankovic [États-Unis] ; Cynthia Comella [États-Unis] ; Angelika Hanschmann [Allemagne] ; Susanne Grafe [Allemagne] | Efficacy and Safety of IncobotulinumtoxinA (NT 201, Xeomin) in the Treatment of Blepharospasm-A Randomized Trial |
| 000689 |
Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Rakesh Shukla [États-Unis] ; Maureen Gartner [États-Unis] ; Alok Sahay [États-Unis] ; Fredy J. Revilla [États-Unis] ; Fredy J. Revilla [États-Unis] ; Andrew P. Duker [États-Unis] | Botulinum Toxin Type A for Levodopa-Induced Cervical Dyskinesias in Parkinson's Disease: Unfavorable Risk-Benefit Ratio |
| 000690 |
Christian Dresel [Allemagne] ; Ferdinand Bayer [Allemagne] ; Florian Castrop [Allemagne] ; Christoph Rimpau [Allemagne] ; Claus Zimmer [Allemagne] ; Bernhard Haslinger [Allemagne] | Botulinum Toxin Modulates Basal Ganglia But Not Deficient Somatosensory Activation in Orofacial Dystonia |
| 000691 |
Maja Kojovic [Royaume-Uni, Slovénie] ; Antonio Caronni [Royaume-Uni, Italie] ; Matteo Bologna [Royaume-Uni, Italie] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] | Botulinum Toxin Injections Reduce Associative Plasticity in Patients with Primary Dystonia |
| 000692 |
Arianna Guidubaldi [Italie] ; Alfonso Fasano [Italie] ; Tamara Lalongo [Italie] ; Carla Piano [Italie] ; Maurizio Pompili [Italie] ; Roberta Masciana [Italie] ; Luisa Siciliani [Italie] ; Mario Sabatelli [Italie] ; Anna Rita Bentivoglio [Italie] | Botulinum Toxin A Versus B in Sialorrhea: A Prospective, Randomized, Double-Blind, Crossover Pilot Study in Patients with Amyotrophic Lateral Sclerosis or Parkinson's Disease |
| 000713 |
Joanna M. Flowers [Royaume-Uni] ; Lucy A. Hicklin [Royaume-Uni] ; Marie-Helene Marion [Royaume-Uni] | Anterior and Posterior Sagittal Shift in Cervical Dystonia: A Clinical and Electromyographic Study, Including a New EMG Approach of the Longus Colli Muscle |
| 000824 |
Urban M. Fietzek [Allemagne] ; A. Sebastian Schroeder [Allemagne] ; Jörg Wissel [Allemagne] ; Florian Heinen [Allemagne] ; Steffen Berweck [Allemagne] | Split-Screen Video Demonstration of Sonography-Guided Muscle Identification and Injection of Botulinum Toxin |
| 000885 |
John W. Dunne [Australie] ; Barbara J. Singer [Australie] ; Peter L. Silbert [Australie] ; Kevin P. Singer [Australie] | Prolonged Vastus Lateralis Denervation After Botulinum Toxin Type A Injection |
| 000968 |
Markus Naumann [Allemagne] ; Alastair Carruthers [Canada] ; Jean Carruthers [Canada] ; Sheena K. Aurora [États-Unis] ; Ross Zafonte [États-Unis] ; Susan Abu-Shakra [États-Unis] ; Terry Boodhoo [États-Unis] ; Mary Ann Miller-Messana [États-Unis] ; George Demos [États-Unis] ; Lynn James [États-Unis] ; Frederick Beddingfield [États-Unis] ; Amanda Vandenburgh [États-Unis] ; Mary Ann Chapman [États-Unis] ; Mitchell F. Brin [États-Unis] | Meta-Analysis of Neutralizing Antibody Conversion with OnabotulinumtoxinA (BOTOX®) Across Multiple Indications |
| 000A14 |
Asunci N Avila [Espagne] ; Plácida Maho [Espagne] ; Juan Bello [Espagne] | Improvement of Orolingual Dyskinesia as a Remote Effect of Botulinum Toxin |
| 000C18 |
Manon Bouchard [Canada] ; Sylvain Chouinard [Canada] ; Oksana Suchowersky [Canada] | Adult Cases of Congenital Muscular Torticollis Successfully Treated with Botulinum Toxin |
| 000D12 |
Friedrich Asmus [Allemagne] ; Rainer Von Coelln [Allemagne] ; Axel Boertlein [Allemagne] ; Thomas Gasser [Allemagne] ; Joerg Mueller [Autriche] | Reverse Sensory Geste in Cervical Dystonia |
| 000D18 |
Gottfried Kranz [Autriche] ; Dietrich Haubenberger [Autriche] ; Bemhard Voller [Autriche] ; Martin Posch [Autriche] ; Peter Schnider [Autriche] ; Eduard Auff [Autriche] ; Thomas Sycha [Autriche] | Respective Potencies of Botox® and Dysport® in a Human Skin Model : A Randomized, Double-blind Study |
| 000D24 |
Joseph Jankovic [États-Unis] ; Christopher Kenney [États-Unis] ; Susanne Grafe [Allemagne] ; Roman Goertelmeyer [Allemagne] ; George Comes [Allemagne] | Relationship Between Various Clinical Outcome Assessments in Patients with Blepharospasm |
| 000D98 |
A. Sebastian Schroeder [Allemagne] ; Birgit Ertl-Wagner [Allemagne] ; Stefanie Britsch [Allemagne] ; J. Michael Schroder [Allemagne] ; Stefan Nikolin [Allemagne] ; Joachim Weis [Allemagne] ; Wolfgang Müller-Felber [Allemagne] ; Inga Koerte [Allemagne] ; Maximilian Stehr [Allemagne] ; Steffen Berweck [Allemagne] ; Ingo Borggraefe [Allemagne] ; Florian Heinen [Allemagne] | Muscle Biopsy Substantiates Long-Term MRI Alterations One Year After A Single Dose of Botulinum Toxin Injected into the Lateral Gastrocnemius Muscle of Healthy Volunteers |
| 000E98 |
Eric S. Molho [États-Unis] ; Nitendra Agarwal [États-Unis] ; Katy Regan [États-Unis] ; Donald S. Higgins [États-Unis] ; Stewart A. Factor [États-Unis] | Effect of Cervical Dystonia on Employment: A Retrospective Analysis of the Ability of Treatment to Restore Premorbid Employment Status |
| 000F54 |
Elisa Pelosin [Italie] ; Marco Bove [Italie] ; Lucio Marinelli [Italie] ; Giovanni Abbruzzese [Italie] ; M. Felice Ghilardi [États-Unis] | Cervical Dystonia Affects Aimed Movements of Nondystonic Segments |
| 000F65 |
Neema Kasravi [Canada] ; Mandar S. Jog [Canada] | Botulinum Toxin in the Treatment of Lingual Movement Disorders |
| 000F66 |
Antonio Emanuele Elia [Italie] ; Graziella Filippini [Italie] ; Daniela Calandrella [Italie] ; Alberto Albanese [Italie] | Botulinum Neurotoxins for Post-Stroke Spasticity in Adults : A Systematic Review |
| 001030 |
Rainer Von Coelln [Allemagne] ; Armin Raible [Allemagne] ; Thomas Gasser [Allemagne] ; Friedrich Asmus [Allemagne] | Ultrasound-Guided Injection of the Iliopsoas Muscle with Botulinum Toxin in Camptocormia |
| 001181 |
Clecio Godeiro-Junior [Brésil] ; André Carvalho Felicio [Brésil] ; Evandro Penteado Villar Felix [Brésil] ; Gilberto Mastrocola Manzano [Brésil] ; Sonia Maria De Azevedo Silva [Brésil] ; Vanderci Borges [Brésil] ; Henrique Ballalai Ferraz [Brésil] ; Orlando G. P. Barsottini [Brésil] | Moving Ear Syndrome : The Role of Botulinum Toxin |
| 001183 |
Joseph Jankovic [États-Unis] ; Aidin Ashoori [États-Unis] | Movement Disorders in Musicians |
| 001204 |
Mitchell F. Brin [États-Unis] ; Cynthia L. Comella [États-Unis] ; Joseph Jankovic [États-Unis] ; Francis Lai [États-Unis] ; Markus Naumann [Allemagne] | Long-Term Treatment with Botulinum Toxin Type A in Cervical Dystonia Has Low Immunogenicity by Mouse Protection Assay |
| 001317 |
Kimiyoshi Arimura [Japon] ; Yumiko Arimura [Japon] ; Yoshiharu Takata [Japon] ; Tomonori Nakamura [Japon] ; Ryuji Kaji [Japon] | Comparative Electrophysiological Study of Response to Botulinum Toxin Type B in Japanese and Caucasians |
| 001343 |
Eric J. Pappert [États-Unis] ; Terry Germanson [Canada] | Botulinum Toxin Type B vs. Type A in Toxin-Naïve Patients with Cervical Dystonia : Randomized, Double-Blind, Noninferiority Trial |
| 001344 |
Martin J. Hecht [Allemagne] ; Henning Stolze [Allemagne] ; Matthias Auf Dem Brinke [Allemagne] ; Ralf Giess [Allemagne] ; Thoams Treig [Allemagne] ; Martin Winterholler [Allemagne] ; Jorg Wissel [Allemagne] | Botulinum Neurotoxin Type A Injections Reduce Spasticity in Mild to Moderate Hereditary Spastic Paraplegia : Report of 19 Cases |
| 001429 |
Tanya Gurevich [Israël] ; Chava Peretz [Israël] ; Orna Moore [Israël] ; Nina Weizmann [Israël] ; Nir Giladi [Israël] | The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease : A double blind placebo-controlled pilot study |
| 001467 |
Kelvin L. Chou [États-Unis] ; Marian Evatt [États-Unis] ; Vanessa Hinson [États-Unis] ; Katie Kompoliti [États-Unis] | Sialorrhea in Parkinson's Disease : A Review |
| 001556 |
Eigild M Ller [Danemark] ; Merete Bakke [Danemark] ; Torben Dalager [Danemark] ; Lene M. Werdelin [Danemark] | Oromandibular dystonia involving the lateral pterygoid muscles : Four cases with different complexity |
| 001584 |
Richard Walsh [Irlande (pays)] ; Michael Hutchinson [Irlande (pays)] | Molding the Sensory Cortex : Spatial Acuity Improves After Botulinum Toxin Treatment for Cervical Dystonia |
| 001690 |
PRAMOD KUMAR PAL [Inde] ; PONNATHPUR SATISH LAKSHMI [Inde] ; Muninarayanappa Nirmala [Inde] | Efficacy and complication of botulinum toxin injection in palatal myoclonus : Experience from a patient |
| 001767 |
Richard M. Trosch [États-Unis] ; Charles H. Adler [États-Unis] ; Eric J. Pappert [États-Unis] | Botulinum toxin type B (Myobloc®) in subjects with hemifacial spasm : Results from an open-label, dose-escalation safety study |
| 001768 |
Laura Bonanni [Italie] ; Astrid Thomas [Italie] ; Sara Varanese [Italie] ; Vincenzo Scorrano [Italie] ; Marco Onofrj [Italie] | Botulinum Toxin Treatment of Lateral Axial Dystonia in Parkinsonism |
| 001780 |
Jörg Müller [Autriche] ; Martina Rinnerthaler [Autriche] ; Werner Poewe [Autriche] ; Markus Kofler [Autriche] | Auditory startle reaction in primary blepharospasm |
| 001781 |
Bradley J. Katz [États-Unis] ; John R. Burroughs [États-Unis] ; Richard L. Anderson [États-Unis] ; Shannon Bownds [États-Unis] ; John D. Mccann [États-Unis] | Asynchronous blepharospasm, facial and cervical dystonia, and bilateral asynchronous hemifacial spasm |
| 001801 |
Sascha Hering [Autriche] ; Gregor K. Wenning [Autriche] ; Klaus Seppi [Autriche] ; Werner Poewe [Autriche] ; Joerg Mueller [Autriche] | An open trial of levetiracetam for segmental and generalized dystonia |
| 001854 |
Daniel Tarsy [États-Unis] ; Susie I. Ro [États-Unis] | Unusual position-sensitive jaw tremor responsive to botulinum toxin |
| 001862 |
Martin A. Ritter [Allemagne] ; Achim Frese [Allemagne] ; Rainer Dziewas [Allemagne] ; Stefan Knecht [Allemagne] ; Stefan Evers [Allemagne] | Treatment of cremaster synkinesias with botulinum toxin A : A video case report |
| 001907 |
Carla Cordivari [Royaume-Uni] ; Vijay Peter Misra [Royaume-Uni] ; Angela Vincent [Royaume-Uni] ; Santiago Catania [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Andrew John Lees [Royaume-Uni] | Secondary nonresponsiveness to botulinum toxin a in cervical dystonia : The role of electromyogram-guided injections, botulinum toxin a antibody assay, and the extensor digitorum brevis test |
| 001921 |
Nam-Jong Paik [Corée du Sud] ; Kyle Seo [Corée du Sud] ; HEE CHUL EUN [Corée du Sud] | Reduced potency after refrigerated storage of botulitum toxin A : Human extensor digitorum brevis muscle study |
| 001949 |
Giovanni Cossu [Italie] ; Alessandra Mereu [Italie] ; Marcello Deriu [Italie] ; Maurizio Melis [Italie] ; Andrea Molari [Italie] ; Giannina Melis [Italie] ; Laura Minafra [Italie] ; Tiziana Pisano [Italie] ; Carlo Cianchetti [Italie] ; Enzo Ortu [Italie] ; Gianfranco Sau [Italie] ; Isidoro Aiello [Italie] ; Miriana Fresu [Italie] ; Maria Giovanna Marrosu [Italie] ; Paolo Contu [Italie] | Prevalence of primary blepharospasm in Sardinia, Italy : A service-based survey |
| 001A43 |
Pedro Gonzalez-Alegre [États-Unis] ; Praful Kelkar [États-Unis] ; Robert L. Rodnitzky [États-Unis] | Isolated high-fequency jaw tremor relieved by botulinum toxin injections |
| 001B63 |
Kazuya Yoshida [Japon] | Coronoidotomy as treatment for trismus due to jaw-closing oromandibular dystonia |
| 001C04 |
Giovanni Lagalla [Italie] ; Marzia Millevolte [Italie] ; Marianna Capecci [Italie] ; Leandro Provinciali [Italie] ; Maria Gabriella Ceravolo [Italie] | Botulinum toxin type a for drooling in Parkinson's disease : A double-blind, randomized, placebo-controlled study |
| 001C05 |
Nina Browner [États-Unis] ; Shaheda N. Azher [États-Unis] ; Joseph Jankovic [États-Unis] | Botulinum toxin treatment of facial myoclonus in suspected rasmussen encephalitis |
| 001C06 |
Carlo Trompetto [Italie] ; Antonio Curra [Italie] ; Alessandro Buccolieri [Italie] ; Antonello Suppa [Italie] ; Giovanni Abbruzzese [Italie] ; Alfredo Berardelli [Italie] | Botulinum toxin changes intrafusal feedback in dystonia : A study with the tonic vibration reflex |
| 001C07 |
Peter N. Van Harten [Pays-Bas] ; Ad Hovestadt [Pays-Bas] | Botulinum toxin as a treatment for tardive dyskinesia |
| 001C08 |
Cristina Tassorelli [Italie] ; Francesca Mancini [Italie] ; Laura Balloni [Italie] ; Claudio Pacchetti [Italie] ; Giorgio Sandrini [Italie] ; Giuseppe Nappi [Italie] ; Emilia Martignoni [Italie] | Botulinum toxin and neuromotor rehabilitation : An integrated approach to idiopathic cervical dystonia |
| 001C09 |
Susanne A. Schneider [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Carla Cordivari [Royaume-Uni] ; William N. Macleod [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease |
| 001C43 |
Pablo Mir [Royaume-Uni, Espagne] ; Francesca Gilio [Italie] ; Mark Edwards [Royaume-Uni] ; Maurizio Inghilleri [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections |
| 001C68 |
Jordan Dubow [États-Unis] ; Angela Kim [États-Unis] ; Jerrold Leikin [États-Unis] ; Kirk Cumpston [États-Unis] ; Sean Bryant [États-Unis] ; Michael Rezak [États-Unis] | Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections |
| 001D27 |
Albert Marchetti [États-Unis] ; Raf Magar [États-Unis] ; Leslie Findley [Royaume-Uni] ; Jan P. Larsen [Norvège] ; Zvezdan Pirtosek [Slovénie] ; Evzen Rauzizka [République tchèque] ; Robert Jech [République tchèque] ; Jaroslaw Slawek [Pologne] ; Fayyaz Ahmed [Royaume-Uni] | Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm : The REAL DOSE study |
| 001D43 |
Carlos Singer [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Neil I. Spielholz [États-Unis] | Primary writing tremor : Report of a case successfully treated with botulinum toxin a injections and discussion of underlying mechanism |
| 001D86 |
Emma Frasson [Italie] ; Alberto Priori [Italie] ; Barbara Ruzzante [Italie] ; Giuseppe Didone [Italie] ; Laura Bertolasi [Italie] | Nerve stimulation boosts botulinum toxin action in spasticity |
| 001D91 |
Dirk Dressler [Allemagne] ; M. Lange [Allemagne] ; Hans Bigalke [Allemagne] | Mouse diaphragm assay for detection of antibodies against botulinum toxin type B |
| 001E02 |
Brian Berman [États-Unis] ; Lauren Seeberger [États-Unis] ; Rajeev Kumar [États-Unis] | Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia |
| 001E04 |
Inger Marie Skogseid [Norvège] ; Jo R Islien [Norvège] ; Bj Rgulf Claussen [Norvège] ; Emilia Kerty [Norvège] | Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia |
| 001E05 |
Nicte I. Mejia [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Joseph Jankovic [États-Unis] | Long-term botulinum toxin efficacy, safety, and immunogenicity |
| 001E47 |
Hans-Christian Jabusch [Allemagne] ; Dorothea Zschucke [Allemagne] ; Alexander Schmidt [Allemagne] ; Stephan Schuele [États-Unis] ; Eckart Altenmüller [Allemagne] | Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients |
| 001E61 |
Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis] ; Sharon Evans [États-Unis] ; Paul J. Feustel [États-Unis] | Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia |
| 001E62 |
Daniel Truong [États-Unis] ; Drake D. Duane [États-Unis] ; Joseph Jankovic [États-Unis] ; Carlos Singer [États-Unis] ; Lauren C. Seeberger [États-Unis] ; Cynthia L. Comella [États-Unis] ; Mark F. Lew [États-Unis] ; Robert L. Rodnitzky [États-Unis] ; Fabio O. Danisi [États-Unis] ; James P. Sutton [États-Unis] ; P. David Charles [États-Unis] ; Robert A. Hauser [États-Unis] ; Geoffrey L. Sheean [États-Unis] | Efficacy and safety of botulinum type A toxin (dysport) in cervical dystonia : Results of the first us randomized, double-blind, placebo-controlled study |
| 001F19 |
Takahiro Mezaki [Japon] ; Rie Sakai [Japon] | Botulinum toxin and skin rash reaction |
| 001F28 |
Mark A. Hirsch [États-Unis, Allemagne] ; Bettina Westhoff [Allemagne] ; Tonya Toole [États-Unis] ; Stephan Haupenthal [Allemagne] ; Rüdiger Krauspe [Allemagne] ; Harald Hefter [Allemagne] | Association between botulinum toxin injection into the arm and changes in gait in adults after stroke |
| 001F66 |
Steffen Berweck [Allemagne] ; Florian Heinen [Allemagne] | Use of botulinum toxin in pediatric spasticity (cerebral palsy) |
| 001F73 |
Giuseppe Brisinda [Italie] ; Anna Rita Bentivoglio [Italie] ; Giorgio Maria [Italie] ; Alberto Albanese [Italie] | Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms |
| 001F74 |
Joseph Jankovic [États-Unis] | Treatment of cervical dystonia with botulinum toxin |
| 001F90 |
Subramanyam Swaminathan [États-Unis] ; Subramanian Eswaramoorthy [États-Unis] ; Desigan Kumaran [États-Unis] | Structure and enzymatic activity of botulinum neurotoxins |
| 002007 |
Charles H. Adler [États-Unis] ; Stephen F. Bansberg [États-Unis] ; Kari Krein-Jones [États-Unis] ; Joseph G. Hentz [États-Unis] | Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia |
| 002055 |
Jean-Michel Gracies [États-Unis] | Physiological effects of botulinum toxin in spasticity |
| 002057 |
Kai Wohlfarth [Allemagne] ; Knut Kampe [Royaume-Uni] ; Hans Bigalke [Allemagne] | Pharmacokinetic properties of different formulations of botulinum neurotoxin type A |
| 002079 |
Bernhard Voller [Autriche] ; Ekaterina Moraru [Autriche] ; Eduard Auff [Autriche] ; Michael Benesch [Autriche] ; Werner Poewe [Autriche] ; Jorg Wissel [Autriche] ; Jorg Müller [Autriche] ; Tanja Entner [Autriche] ; Hans Bigalke [Allemagne] ; Peter Schnider [Autriche] | Ninhydrin sweat test: A simple method for detecting antibodies neutralizing botulinum toxin type A |
| 002080 |
Carla Cordivari [Royaume-Uni] ; V. Peter Misra [Royaume-Uni] ; Santiago Catania [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | New therapeutic indications for botulinum toxins |
| 002097 |
Dorothy D. Whelchel [États-Unis] ; Tonia M. Brehmer [États-Unis] ; Paula M. Brooks [États-Unis] ; Neely Darragh [États-Unis] ; Julie A. Coffield [États-Unis] | Molecular targets of botulinum toxin at the mammalian neuromuscular junction |
| 002110 |
Peter Haussermann [Allemagne] ; Stefanie Marczoch [Allemagne] ; Christiane Klinger [Allemagne] ; Michael Landgrebe [Allemagne] ; Bastian Conrad [Allemagne] ; Andres Ceballos-Baumann [Allemagne] | Long-term follow-up of cervical dystonia patients treated with botulinum toxin A |
| 002122 |
Ester Fernandez-Salas [États-Unis] ; Helen Ho [États-Unis] ; Patton Garay [États-Unis] ; Lance E. Steward [États-Unis] ; K. Roger Aoki [États-Unis] | Is the light chain subcellular localization an important factor in botulinum toxin duration of action? |
| 002139 |
Frank J. Erbguth [Allemagne] | Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin |
| 002178 |
Roberto Eleopra [Italie] ; Valeria Tugnoli [Italie] ; Rocco Quatrale [Italie] ; Ornella Rossetto [Italie] ; Cesare Montecucco [Italie] | Different types of botulinum toxin in humans |
| 002186 |
Dorothea Sesardic [Royaume-Uni] ; Russell G. A. Jones [Royaume-Uni] ; Tong Leung [Royaume-Uni] ; Toni Alsop [Royaume-Uni] ; Robert Tierney [Royaume-Uni] | Detection of antibodies against botulinum toxins |
| 002190 |
James D. Marks [États-Unis] | Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization |
| 002194 |
Birgit Herring [Allemagne] ; Silke Wunderlich [Allemagne] ; Theresa Glöckler [Allemagne] ; Martin Bendszus [Allemagne] ; Dirk Mucha [Allemagne] ; Heinz Reichmann [Allemagne] ; Markus Naumann [Allemagne] | Computed tomographically controlled injection of botulinum toxin into the longus colli muscle in severe anterocollis |
| 002203 |
Dirk Dressier [Allemagne] | Clinical presentation and management of antibody-induced failure of botulinum toxin therapy |
| 002206 |
Cristina Sampaio [Portugal] ; Joao Costa [Portugal] ; Joaquim J. Ferreira [Portugal] | Clinical comparability of marketed formulations of botulinum toxin |
| 002219 |
Antonio Curra [Italie] ; Carlo Trompetto [Italie] ; Giovanni Abbruzzese [Italie] ; Alfredo Berardelli [Italie] | Central effects of botulinum toxin type A: Evidence and supposition |
| 002224 |
William J. Newman [États-Unis] ; Thomas L. Davis [États-Unis] ; Bismal B. Padaliya [États-Unis] ; Cassondra D. Covington [États-Unis] ; Chandler E. Gill [États-Unis] ; Anna I. Ahramovitch [États-Unis] ; P. David Charles [États-Unis] | Botulinum toxin type A therapy during pregnancy |
| 002225 |
Markus Naumann [Allemagne] ; Wolfgang Jost [Allemagne] | Botulinum toxin treatment of secretory disorders |
| 002226 |
Barbara Illowsky Karp [États-Unis] | Botulinum toxin treatment of occupational and focal hand dystonia |
| 002227 |
Wolfgang H. Jost [Allemagne] ; Markus Naumann [Allemagne] | Botulinum toxin in neuro-urological disorders |
| 002233 |
M. Zouhair Atassi [États-Unis] | Basic immunological aspects of botulinum toxin therapy |
| 002478 |
Francesca Mancini [Italie] ; Roberta Zangaglia [Italie] ; Silvano Cristina [Italie] ; Maria Grazia Sommaruga [Italie] ; Emilia Martignoni [Italie] ; Giuseppe Nappi [Italie] ; Claudio Pacchetti [Italie] | Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of Drooling in parkinsonism |
| 002617 |
Brad A. Racette [États-Unis] ; Mikula Stambuk [États-Unis] ; Joel S. Perlmutter [États-Unis] | Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024) |
| 002618 |
Charles H. Adler [États-Unis] ; Stewart A. Factor [États-Unis] ; Mitchell Brin [États-Unis] ; Kapil D. Sethi [États-Unis] | Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia |
| 002662 |
Alfredo Berardelli [Italie] ; Antonio Curra [Italie] | Pathophysiology and treatment of cranial dystonia |
| 002702 |
G-Y. R. Hsiung [Canada] ; S. K. Das [Canada] ; R. Ranawaya [Canada] ; A.-L. Lafontaine [Canada] ; O. Suchowersky [Canada] | Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period |
| 002842 |
Dirk Dressler [Royaume-Uni] ; Hans Bigalke [Allemagne] | Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy |
| 002843 |
C. Detrembleur [Belgique] ; T. M. Lejeune [Belgique] ; A. Renders [Belgique] ; P. Y. K. Van Den Bergh [Belgique] | Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy |
| 002A88 |
D. Dressler [Allemagne] ; M. Wittstock [Allemagne] ; R. Benecke [Allemagne] | Treatment of persistent hemiballism with botulinum toxin type A |
| 002B12 |
F. Birklein [Allemagne] ; F. Erbguth [Allemagne] | Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A : A preliminary observation |
| 002B47 |
A. Brashear [États-Unis] ; K. Bergan [États-Unis] ; J. Wojcieszek [États-Unis] ; E. R. Siemers [États-Unis] ; W. Ambrosius [États-Unis] | Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A |
| 002C42 |
Dirk Dressler [Allemagne] ; Uwe Zettl [Allemagne] ; Reiner Benecke [Allemagne] ; Hans Bigalke [Allemagne] | Can intravenous immunoglobulin improve antibody-mediated botulinum toxin therapy failure? |
| 002C46 |
A. Rapaport [Israël] ; M. Sadeh [Israël] ; D. Stein [Israël] ; J. Levine [Israël] ; P. Sirota [Israël] ; T. Mosheva [Israël] ; S. Stir [Israël] ; A. Elitzur [Israël] ; I. Reznik [Israël] ; D. Geva [Israël] ; J. M. Rabev [Israël] | Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia |
| 002C47 |
D. Dressier [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni] | Botulinum toxin antibody testing : Comparison between the mouse protection assay and the mouse lethality assay |
